Trial
NCT01905605
Phosphatidylcholine Supplementation in Infants
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
—
Condition
Schizophrenia
Intervention
phosphatidylcholine supplementation
Why stopped
Funding not secured. IRB approval has been withdrawn as of January 2017.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-02